Car t-cells comprising inactivated CBL and CBL-B genes
US12187780B2 · kind B2 · utility
0Cited by
0References
8Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 23, 2018 |
| Grant date | Jan 7, 2025 |
| Priority date | — |
| Expiry date | Dec 20, 2040 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2310/14
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Methods and compositions for treating cancer, particularly improved CAR-T methods, are disclosed.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.